Stay updated with breaking news from Davidj Nutt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Academics and researchers in psychiatry and psychopharmacology criticize a review that questions the serotonin hypothesis of depression ― a bedrock principle of depression treatment.
Experts Discuss Psychedelics Policy in the Global North at Harvard Law School Webinar | News | The Harvard Crimson
The drug MDMA (3,4-methylenedioxymethamphetamine) might not produce depressive "comedowns" when used in a controlled clinical setting, according to new research published in the Journal of Psychopharmacology. The findings offers some initial evidence that declines in mood and cognition in the days following MDMA use are produced by factors related to recreational consumption. ...
Results of a case study in children prompt researchers to call for further exploration of the potential therapeutic benefits of whole-plant medicinal cannabis products.